Evidence map›Paper›PMID 32123192›Full record

ArticleScientific reports2020

The unique expression profile of FAM19A1 in the mouse brain and its association with hyperactivity, long-term memory and fear acquisition.

Hyo Jeong Yong, Nui Ha, Eun Bee Cho, Seongsik Yun, Hyun Kim, Jong-Ik Hwang, Jae Young Seong

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Can Adipokine FAM19A5 Be a Biomarker of Metabolic Disorders?Diabetes, metabolic syndrome and obesity : targets and therapy · 2024
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Hyo Jeong YongThe GPCR laboratory, Graduate School of Biomedical Science, Korea University College of Medicine, Seoul, 02841, Republic of Korea.
Nui HaNeuracle Science Co. Ltd., Seoul, 02841, Republic of Korea.
Eun Bee ChoNeuracle Science Co. Ltd., Seoul, 02841, Republic of Korea.
Seongsik YunThe GPCR laboratory, Graduate School of Biomedical Science, Korea University College of Medicine, Seoul, 02841, Republic of Korea.
Hyun KimDepartment of Anatomy, Korea University College of Medicine, Seoul, 02841, Republic of Korea.
Jong-Ik HwangThe GPCR laboratory, Graduate School of Biomedical Science, Korea University College of Medicine, Seoul, 02841, Republic of Korea. hjibio@korea.ac.kr.ORCID http://orcid.org/0000-0002-0729-1782
Jae Young SeongThe GPCR laboratory, Graduate School of Biomedical Science, Korea University College of Medicine, Seoul, 02841, Republic of Korea. jyseong@korea.ac.kr.
Korea University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurodevelopment and mature brain function are spatiotemporally regulated by various cytokines and chemokines. The chemokine-like neuropeptide FAM19A1 is a member of family with sequence similarity 19 (FAM19), which is predominantly expressed in the brain. Its highly conserved amino acid sequence among vertebrates suggests that FAM19A1 may play important physiological roles in neurodevelopment and brain function. Here we used a LacZ reporter gene system to map the expression pattern of the FAM19A1 gene in the mouse brain. The FAM19A1 expression was observed in several brain regions starting during embryonic brain development. As the brain matured, the FAM19A1 expression was detected in the pyramidal cells of cortical layers 2/3 and 5 and in several limbic areas, including the hippocampus and the amygdala. FAM19A1-deficient mice were used to evaluate the physiological contribution of FAM19A1 to various brain functions. In behavior analysis, FAM19A1-deficient mice exhibited several abnormal behaviors, including hyperactive locomotor behavior, long-term memory deficits and fear acquisition failure. These findings provide insight into the potential contributions of FAM19A1 to neurodevelopment and mature brain function.

Indexed as

Behavior, AnimalConditioning, PsychologicalAmygdalaAnimalsBrainChemokinesFearFemaleHippocampusHyperkinesisMaleMemory, Long-TermMiceMice, KnockoutChemokinesTafa1 protein, mouse

Identifiers

PMID32123192
PMCPMC7052240
OpenAlexW3010080385

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.